A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development: IUPHAR Review 29

Author:

Alexander Steve P.H.1ORCID,Armstrong Jane F.2ORCID,Davenport Anthony P.3ORCID,Davies Jamie A.4ORCID,Faccenda Elena2ORCID,Harding Simon D.5ORCID,Levi‐Schaffer Francesca6ORCID,Maguire Janet J.7ORCID,Pawson Adam J.8ORCID,Southan Christopher910ORCID,Spedding Michael11ORCID

Affiliation:

1. Chair, Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC‐IUPHAR), School of Life Sciences University of Nottingham Nottingham UK

2. Curator, Guide to PHARMACOLOGY (GtoPdb), Deanery of Biomedical Sciences University of Edinburgh Edinburgh UK

3. Executive Committee, NC‐IUPHAR University of Cambridge Cambridge UK

4. Principal Investigator, Guide to PHARMACOLOGY (GtoPdb), Executive Committee, NC‐IUPHAR, Deanery of Biomedical Sciences University of Edinburgh Edinburgh UK

5. Database Developer, Guide to PHARMACOLOGY (GtoPdb), Deanery of Biomedical Sciences University of Edinburgh Edinburgh UK

6. First Vice‐President and Chair of Immunopharmacology Section, International Union of Basic and Clinical Pharmacology (IUPHAR) Hebrew University of Jerusalem Jerusalem Israel

7. University of Cambridge Cambridge UK

8. Senior Curator, Guide to PHARMACOLOGY (GtoPdb), Executive Committee, NC‐IUPHAR, Deanery of Biomedical Sciences University of Edinburgh Edinburgh UK

9. Deanery of Biomedical Sciences University of Edinburgh Edinburgh UK

10. TW2Informatics Ltd Gothenburg Sweden

11. Secretary‐General, International Union of Basic and Clinical Pharmacology (IUPHAR) and Spedding Research Solutions SAS Le Vesinet France

Funder

Wellcome Trust

Publisher

Wiley

Subject

Pharmacology

Reference242 articles.

1. Catalytic cleavage of the androgen‐regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia;Afar D. E.;Cancer Research,2001

2. The Concise Guide to PHARMACOLOGY 2019/20: Introduction and Other Protein Targets;Alexander S. P. H.;British Journal of Pharmacology,2019

3. SARS-CoV-2 Vaccines: Status Report

4. Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs

5. COVID‐2019: The role of the nsp2 and nsp3 in its pathogenesis

Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3